BEAM vs CSQR Comparison

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Csquare Inc is an enterprise digital infrastructure platform, owning and operating a geographically diverse portfolio of carrier-neutral data centers located across the United States, Canada and the United Kingdom. The company provides carrier-neutral colocation and interconnection services that provide infrastructure, including space, power, cooling systems, physical security, and interconnection capabilities, enabling customers to deploy and operate IT and network infrastructure. Its facilities support enterprise, network, cloud, and technology customers in the deployment and operation of IT and network infrastructure. The company generates the majority of its revenue from enterprise colocation services, which include fees for the licensing of cabinet space and power.